Statistics

Total Visits

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)41

Select a period of time:

Number of views in the range

Views
Biweekly cetuximab in combination with FOLFOX-4 in the first-line treatment of wild-type KRAS metastatic colorectal cancer: Final results of a phase II, open-label, clinical trial (OPTIMIX-ACROSS Study)21

Views

Views
January 20251
February 20253
March 202514
April 20252
May 20251
June 20250
July 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore14
United States5
Spain2
 

Top cities views

Views
Buffalo2
Council Bluffs1
Valencia1